Matrix Metallopeptidase 9 As a Host Protein Target of Chloroquine and Melatonin for Immunoregulation in COVID-19: A Network-based Meta-analysis

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2020 Jul 18

PMID 32679150

Citations 36

Authors

Suvojit Hazra

Alok Ghosh Chaudhuri

Basant K Tiwary

Nilkanta Chakrabarti

Affiliations

Soon will be listed here.

Abstract

Aims: The molecular pathogenesis of COVID-19 is similar to other coronavirus (CoV) infections viz. severe acute respiratory syndrome (SARS) in human. Due to scarcity of the suitable treatment strategy, the present study was undertaken to explore host protein(s) targeted by potent repurposed drug(s) in COVID-19.

Materials And Methods: The differentially expressed genes (DEGs) were identified from microarray data repository of SARS-CoV patient blood. The repurposed drugs for COVID-19 were selected from available literature. Using DEGs and drugs, the protein-protein interaction (PPI) and chemo-protein interaction (CPI) networks were constructed and combined to develop an interactome model of PPI-CPI network. The top-ranked sub-network with its hub-bottleneck nodes were evaluated with their functional annotations.

Key Findings: A total of 120 DEGs and 65 drugs were identified. The PPI-CPI network (118 nodes and 293 edges) exhibited a top-ranked sub-network (35 nodes and 174 connectivities) with 12 hub-bottleneck nodes having two drugs chloroquine and melatonin in association with 10 proteins corresponding to six upregulated and four downregulated genes. Two drugs interacted directly with the hub-bottleneck node i.e. matrix metallopeptidase 9 (MMP9), a host protein corresponding to its upregulated gene. MMP9 showed functional annotations associated with neutrophil mediated immunoinflammation. Moreover, literature survey revealed that angiotensin converting enzyme 2, a membrane receptor of SARS-CoV-2 virus, might have functional cooperativity with MMP9 and a possible interaction with both drugs.

Significance: The present study reveals that between chloroquine and melatonin, melatonin appears to be more promising repurposed drug against MMP9 for better immunocompromisation in COVID-19.

Citing Articles

Analysis of differential expression of matrix metalloproteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases.

Imtiaz K, Farooqui N, Ahmed K, Zhamalbekova A, Anwar M, Nasir A PLoS One. 2025; 20(2):e0304311.

PMID: 39965032 PMC: 11835293. DOI: 10.1371/journal.pone.0304311.

Metabolomic Approach to Identify the Potential Metabolites from Alpinia malaccensis for Treating SARS-CoV-2 Infection.

Jahan E, Mazumder T, Hasan T, Ahmed K, Amanat M, Hossain H Biochem Genet. 2024; .

PMID: 38955878 DOI: 10.1007/s10528-024-10869-4.

A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review).

Lempesis I, Georgakopoulou V, Reiter R, Spandidos D Int J Mol Med. 2024; 53(3).

PMID: 38299237 PMC: 10852014. DOI: 10.3892/ijmm.2024.5352.

Sex-specific differences in systemic immune responses in MIS-C children.

Rajamanickam A, Kumar N, Venkataraman A, Varadarjan P, Selladurai E, Sankaralingam T Sci Rep. 2024; 14(1):1720.

PMID: 38243064 PMC: 10799056. DOI: 10.1038/s41598-024-52116-1.

Elevated matrix metalloproteinase‑9 expression is associated with COVID‑19 severity: A meta‑analysis.

Ding L, Guo H, Zhang C, Jin H, Guo X, Li T Exp Ther Med. 2023; 26(6):545.

PMID: 37928509 PMC: 10623216. DOI: 10.3892/etm.2023.12244.

References

Loffek S, Schilling O, Franzke C . Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2010; 38(1):191-208. DOI: 10.1183/09031936.00146510. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Aitken E, Alemu A, Rogerson S . Neutrophils and Malaria. Front Immunol. 2019; 9:3005. PMC: 6306064. DOI: 10.3389/fimmu.2018.03005. View

Smyth G . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2006; 3:Article3. DOI: 10.2202/1544-6115.1027. View

Zhang L, Liu Y . Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020; 92(5):479-490. PMC: 7166986. DOI: 10.1002/jmv.25707. View

Tian X, Li C, Huang A, Xia S, Lu S, Shi Z . Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9(1):382-385. PMC: 7048180. DOI: 10.1080/22221751.2020.1729069. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Lesiak A, Narbutt J, Sysa-Jedrzejowska A, Lukamowicz J, McCauliffe D, Wozniacka A . Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus. Lupus. 2010; 19(6):683-8. DOI: 10.1177/0961203309356455. View

Vinetz J . Lack of efficacy of hydroxychloroquine in covid-19. BMJ. 2020; 369:m2018. DOI: 10.1136/bmj.m2018. View

10.

Radogna F, Diederich M, Ghibelli L . Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol. 2010; 80(12):1844-52. DOI: 10.1016/j.bcp.2010.07.041. View

11.

Skariyachan S, Challapilli S, Packirisamy S, Kumargowda S, Sridhar V . Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections. Front Microbiol. 2019; 10:569. PMC: 6448012. DOI: 10.3389/fmicb.2019.00569. View

12.

Yu C, Wong R, Wu E, Kong S, Wong J, Yip G . Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140-4. PMC: 2596695. DOI: 10.1136/pgmj.2005.037515. View

13.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

14.

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

15.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

16.

Batlle D, Wysocki J, Satchell K . Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?. Clin Sci (Lond). 2020; 134(5):543-545. DOI: 10.1042/CS20200163. View

17.

Hernandez A, Roman Y, Pasupuleti V, Barboza J, White C . Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Ann Intern Med. 2020; 173(4):287-296. DOI: 10.7326/M20-2496. View

18.

Kapoor C, Vaidya S, Wadhwan V, Kaur G, Pathak A . Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther. 2016; 12(1):28-35. DOI: 10.4103/0973-1482.157337. View

19.

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

20.

Tan D, Korkmaz A, Reiter R, Manchester L . Ebola virus disease: potential use of melatonin as a treatment. J Pineal Res. 2014; 57(4):381-4. DOI: 10.1111/jpi.12186. View